190 related articles for article (PubMed ID: 38369827)
21. Advances in the application of CRISPR-Cas technology in rapid detection of pathogen nucleic acid.
Li X; Zhong J; Li H; Qiao Y; Mao X; Fan H; Zhong Y; Imani S; Zheng S; Li J
Front Mol Biosci; 2023; 10():1260883. PubMed ID: 37808520
[No Abstract] [Full Text] [Related]
22. CRISPR/Cas-engineered technology: Innovative approach for biosensor development.
Zavvar TS; Khoshbin Z; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
Biosens Bioelectron; 2022 Oct; 214():114501. PubMed ID: 35777218
[TBL] [Abstract][Full Text] [Related]
23. CRISPR technology incorporating amplification strategies: molecular assays for nucleic acids, proteins, and small molecules.
Feng W; Newbigging AM; Tao J; Cao Y; Peng H; Le C; Wu J; Pang B; Li J; Tyrrell DL; Zhang H; Le XC
Chem Sci; 2021 Mar; 12(13):4683-4698. PubMed ID: 34163728
[TBL] [Abstract][Full Text] [Related]
24. CRISPR-Cas based virus detection: Recent advances and perspectives.
Yin L; Man S; Ye S; Liu G; Ma L
Biosens Bioelectron; 2021 Dec; 193():113541. PubMed ID: 34418634
[TBL] [Abstract][Full Text] [Related]
25. CRISPR/cas systems redefine nucleic acid detection: Principles and methods.
Wang M; Zhang R; Li J
Biosens Bioelectron; 2020 Oct; 165():112430. PubMed ID: 32729545
[TBL] [Abstract][Full Text] [Related]
26. Photoactivatable CRISPR/Cas12a Sensors for Biomarkers Imaging and Point-of-Care Diagnostics.
Li QN; Wang DX; Chen DY; Lyu JA; Wang YX; Wu SL; Jiang HX; Kong DM
Anal Chem; 2024 Feb; 96(6):2692-2701. PubMed ID: 38305871
[TBL] [Abstract][Full Text] [Related]
27. [Application of CRISPR/Cas systems in the nucleic acid detection of pathogens: a review].
Li M; Qin Z; Yin K; Zheng B
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2023 Feb; 35(1):98-103. PubMed ID: 36974023
[TBL] [Abstract][Full Text] [Related]
28. CRISPR-induced DNA reorganization for multiplexed nucleic acid detection.
Karlikow M; Amalfitano E; Yang X; Doucet J; Chapman A; Mousavi PS; Homme P; Sutyrina P; Chan W; Lemak S; Yakunin AF; Dolezal AG; Kelley S; Foster LJ; Harpur BA; Pardee K
Nat Commun; 2023 Mar; 14(1):1505. PubMed ID: 36932065
[TBL] [Abstract][Full Text] [Related]
29. An Update of Nucleic Acids Aptamers Theranostic Integration with CRISPR/Cas Technology.
Roueinfar M; Templeton HN; Sheng JA; Hong KL
Molecules; 2022 Feb; 27(3):. PubMed ID: 35164379
[TBL] [Abstract][Full Text] [Related]
30. CRISPR-Cas-based techniques for pathogen detection: Retrospect, recent advances, and future perspectives.
Huang T; Zhang R; Li J
J Adv Res; 2023 Aug; 50():69-82. PubMed ID: 36367481
[TBL] [Abstract][Full Text] [Related]
31. Cas14a1-mediated nucleic acid detectifon platform for pathogens.
Ge X; Meng T; Tan X; Wei Y; Tao Z; Yang Z; Song F; Wang P; Wan Y
Biosens Bioelectron; 2021 Oct; 189():113350. PubMed ID: 34049081
[TBL] [Abstract][Full Text] [Related]
32. CRISPR-Cas Biochemistry and CRISPR-Based Molecular Diagnostics.
Weng Z; You Z; Yang J; Mohammad N; Lin M; Wei Q; Gao X; Zhang Y
Angew Chem Int Ed Engl; 2023 Apr; 62(17):e202214987. PubMed ID: 36710268
[TBL] [Abstract][Full Text] [Related]
33. Universal smartphone-assisted label-free CRISPR/Cas12a-DNAzyme chemiluminescence biosensing platform for on-site detection of nucleic acid and non-nucleic acid targets.
Chen H; Feng Y; Liu F; Tan C; Xu N; Jiang Y; Tan Y
Biosens Bioelectron; 2024 Mar; 247():115929. PubMed ID: 38128320
[TBL] [Abstract][Full Text] [Related]
34. Fluorescence Signal-Readout of CRISPR/Cas Biosensors for Nucleic Acid Detection.
Huang Z; Liu S; Pei X; Li S; He Y; Tong Y; Liu G
Biosensors (Basel); 2022 Sep; 12(10):. PubMed ID: 36290917
[TBL] [Abstract][Full Text] [Related]
35. CRISPR/Cas Systems towards Next-Generation Biosensing.
Li Y; Li S; Wang J; Liu G
Trends Biotechnol; 2019 Jul; 37(7):730-743. PubMed ID: 30654914
[TBL] [Abstract][Full Text] [Related]
36. CRISPR-Cas-Integrated LAMP.
Atçeken N; Yigci D; Ozdalgic B; Tasoglu S
Biosensors (Basel); 2022 Nov; 12(11):. PubMed ID: 36421156
[TBL] [Abstract][Full Text] [Related]
37. CRISPR/Cas-powered nanobiosensors for diagnostics.
Phan QA; Truong LB; Medina-Cruz D; Dincer C; Mostafavi E
Biosens Bioelectron; 2022 Feb; 197():113732. PubMed ID: 34741959
[TBL] [Abstract][Full Text] [Related]
38. Advances in biosensing: The CRISPR/Cas system as a new powerful tool for the detection of nucleic acids.
Bonini A; Poma N; Vivaldi F; Kirchhain A; Salvo P; Bottai D; Tavanti A; Di Francesco F
J Pharm Biomed Anal; 2021 Jan; 192():113645. PubMed ID: 33039910
[TBL] [Abstract][Full Text] [Related]
39. Nucleic Acid Detection Using CRISPR/Cas Biosensing Technologies.
Aman R; Mahas A; Mahfouz M
ACS Synth Biol; 2020 Jun; 9(6):1226-1233. PubMed ID: 32159950
[TBL] [Abstract][Full Text] [Related]
40. Microfluidics: the propellant of CRISPR-based nucleic acid detection.
Chen Y; Qian S; Yu X; Wu J; Xu J
Trends Biotechnol; 2023 Apr; 41(4):557-574. PubMed ID: 35989112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
